North America Startup Funding Rounds

Playfly Sports helps brands and sports rights holders generate revenue through media sales, sponsorships, marketing and fan-focused technology. It connects brands with professional and collegiate teams, leagues and athletic departments, using sales and services to package, activate and measure sports partnerships.

Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity.

empirik gives engineering teams an AI agent and live graph of their cloud, on-premises and SaaS estate to assess infrastructure changes before execution. It connects a proposed change to affected resources and services, calculates its blast radius, and routes a plan through approval, execution and verification workflows.

Wafer runs AI inference infrastructure that adapts a model-serving stack to each customer's workload. It benchmarks and tunes models, engines, kernels and available hardware together, then keeps optimizing live serving for latency, reliability and cost as traffic changes.

Hi Rasmus provides an ABA-focused clinical platform for behavioral-health organizations, schools, practitioners, and families.

Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient.

Capacity combines AI support agents, human-agent assistance, quality checks and conversational analytics in a customer-support platform.

A physics-acceleration platform that applies quantum and hybrid quantum-classical algorithms to complex engineering simulations and optimization problems.

Konko AI builds Kora, a patient-communications assistant for clinics and hospitals.

N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers.